• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Agisten Solution
    / Perrigo


    Active Ingredient

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Solution

    20 ml

    full basket chart 229 1160

    Dosage

    To ensure complete healing, treatment should be continued for about 2 weeks after the disappearance of the subjective symptoms. The following are the usual periods of treatment:
    Dermatomycoses: 3-4 weeks
    Erythrasma: 2-4 weeks
    Pityriasis versicolor: 1-3 weeks
    Candida vulvitis and balanitis: 1-2 weeks
    A thin layer should be applied to the affected sites and gently rubbed in 2-3 times daily. A few drops is sufficient to treat an area about the size of a hand.


    Indications

    Skin infections caused by dermatophytes or candida species.


    Contra-Indications

    Hypersensitivity to the active substance or to any of the excipients, including cetostearyl alcohol.
    Do not use the cream to treat nail or scalp infections.


    Special Precautions

    Agisten cream contains cetostearyl alcohol, which may cause local skin reactions (e.g. contact dermatitis). Avoid contact with the eyes.


    Side Effects

    As the listed undesirable effects are based on spontaneous reports, assigning an accurate frequency of occurrence for each is not possible.
    Immune system disorders: allergic reaction (syncope, hypotension, dyspnea,
    urticaria).
    Signs of an allergic reaction may include: rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue, weakness, feeling dizzy or faint, nausea.
    Skin and subcutaneous tissue disorders: blisters, discomfort/pain, oedema, erythema, irritation, peeling/exfoliation, pruritus, rash, stinging/burning.


    Drug interactions

    Laboratory tests have suggested that, when Clotrimazole cream is used together, this product may cause damage to latex contraceptives. Consequently the effectiveness of such contraceptives may be reduced. Patients should be advised to use alternative precautions for at least five days after using this product.


    Overdose

    No risk of acute intoxication is seen as it is unlikely to occur following a single
    dermal application of an overdose (application over a large area under conditions favourable to absorption) or inadvertent oral ingestion. There is no specific antidote.
    However, in the event of accidental oral ingestion, routine measures such as gastric lavage should be performed only if clinical symptoms of overdose become apparent (e.g. dizziness, nausea or vomiting). Gastric lavage should be carried out only if the airway can be protected adequately.


    Manufacturer
    Perrigo Israel
    CLOSE